Found 1825 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., Isolation of two subpopulations of Mycobacterium avium within human macrophages., FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.
L. E. Bermudez, Motamedi, N., Kolonoski, P., Chee, C., Baimukanova, G., Bildfell, R. J., Wang, G., Phan, L. Tam, and S Lowell, Y., The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection., The Journal of infectious diseases, vol. 197, no. 11, pp. 1506-10, 2008.
L. E. Bermudez, Wu, M., and Young, L. S., Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium., Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease., The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Young, L. S., and Gupta, S., 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF., Cellular immunology, vol. 127, no. 2, pp. 432-41, 1990.
L. E. Bermudez, Sangari, F. J., and Parker, A., Green fluorescent protein in the measurement of bacteria-host interactions., Methods in enzymology, vol. 302, pp. 285-95, 1999.
L. E. Bermudez, Danelishvili, L., and Early, J., Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival., Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells., Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S., Naturally occurring antibodies against Mycobacterium avium complex., Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. E. Bermudez, Parker, A., and Goodman, J. R., Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway., Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages., Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, [Post-antibiotic effect in the treatment of infections in neutropenic patients]., Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B., Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model., The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez and Yamazaki, Y., Effects of macrolides and ketolides on mycobacterial infections., Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. E. Bermudez and Young, L. S., Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines., The Journal of infectious diseases, vol. 163, no. 6, pp. 1286-92, 1991.
L. E. Bermudez and Petrofsky, M., Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells., Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.
L. E. Bermudez and Young, L. S., Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines., Research in microbiology, vol. 141, no. 2, pp. 241-3, 1990.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice., Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T., Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages., Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
L. E. Bermudez, Wu, M., and Young, L. S., Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin., The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez and Inderlied, C. B., Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages., Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez and Champsi, J., Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice., Infection and immunity, vol. 61, no. 7, pp. 3093-7, 1993.
L. E. Bermudez and Sangari, F. J., Mycobacterial invasion of epithelial cells., Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S., Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice., The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Parker, A., and Petrofsky, M., Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases., Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.

Pages